We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




First of Its Kind Universal Tool to Revolutionize Sample Collection for Diagnostic Tests

By LabMedica International staff writers
Posted on 29 Apr 2024

The COVID pandemic has dramatically reshaped the perception of diagnostics. More...

Post the pandemic, a groundbreaking device that combines sample collection and processing into a single, easy-to-use disposable unit could revolutionize the way samples are collected for diagnostic tests.

ReadyGo Diagnostics’ (Bath, UK) Sampler device incorporates both the swab and collection buffers into one device, making it exceptionally user-friendly. It is the world’s first universal tool of its kind that ensures convenience, reliability, and reproducibility right from the initial step of a diagnostic test. The patented technology behind the ReadyGo Sampler uses specially engineered materials that not only allow the device to collect the exact amount of sample required instantly but also rapidly break open viruses and bacteria, making them readily detectable in specific tests. The ReadyGo Sampler device is intended to be a more user-oriented alternative to conventional swab-based sample collection methods by combining sample collection and processing into one disposable product.

This device is versatile, and compatible with various types of assays and uses, facilitating a swift and simple collection process that takes as little as five seconds. The Sampler is designed to cater to both consumer and professional testing markets and can accommodate various sample types such as saliva, buccal, blood, and urine. The patented Sampler device works with molecular tests like PCR and isothermal chemistries such as LAMP and RPA. Additionally, it is suitable for use in front of next-generation sequencing (NGS) protocols, including targeted sequencing and whole genome amplification (WGA). The technology allows for easy adaptation to incorporate other test chemistries, broadening its application to include simplified methods for biochemistry testing of physiological markers related to health and disease.

Related Links:
ReadyGo Diagnostics


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Urine Analyzer
respons® UDS100
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Molecular Diagnostics

view channel
Image: Skin samples from people with a suspected genetic myopathy were examined for confirmation of disease. Brown spots show abnormal protein buildup inside the nuclei of cells (purple), typical of a type of myopathy called oculopharyngodistal myopathy. (Image Credit: Garvan Institute)

Long-Read Sequencing Test Identifies Genetic Causes in Inherited Muscle Disease

Inherited muscle diseases are highly heterogeneous and often progressive, leaving many patients without a molecular diagnosis despite extensive testing. Conventional assays typically target individual... Read more

Immunology

view channel
Image: The testing approach is designed for people with HIV whose viral load rises while taking dolutegravir, aiming to limit the accumulation and spread of drug resistance in resource-limited settings. (Image Credit: Shutterstock)

HIV Monitoring Strategy Uses Drug Levels to Guide Resistance Testing

HIV viral load can rise during antiretroviral therapy for reasons that do not necessarily indicate drug resistance. Clinicians must distinguish between treatment nonadherence and resistance before deciding... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.